GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Frelii Inc (GREY:FRLI) » Definitions » YoY EBITDA Growth

Frelii (Frelii) YoY EBITDA Growth : 8.47% (As of Sep. 2019)


View and export this data going back to 2004. Start your Free Trial

What is Frelii YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Frelii's YoY EBITDA Growth for the quarter that ended in Sep. 2019 was 8.47%.

Frelii's EBITDA per Share for the three months ended in Sep. 2019 was $-0.05.

Frelii YoY EBITDA Growth Historical Data

The historical data trend for Frelii's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frelii YoY EBITDA Growth Chart

Frelii Annual Data
Trend May09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.68 -2.75 2.14 100.10 -263.16

Frelii Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -100.24 -115.00 68.97 40.35 8.47

Frelii YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Frelii's YoY EBITDA Growth for the fiscal year that ended in Dec. 2018 is calculated as:

YoY EBITDA Growth (A: Dec. 2018 )
=(EBITDA per Share (A: Dec. 2018 )-EBITDA per Share (A: Dec. 2017 ))/ | EBITDA per Share (A: Dec. 2017 ) |
=(-0.155-0.095)/ | 0.095 |
=-263.16 %

Frelii's YoY EBITDA Growth for the quarter that ended in Sep. 2019 is calculated as:

YoY EBITDA Growth (Q: Sep. 2019 )
=(EBITDA per Share (Q: Sep. 2019 )-EBITDA per Share (Q: Sep. 2018 )) / | EBITDA per Share (Q: Sep. 2018 )) |
=(-0.054--0.059)/ | -0.059 |
=8.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frelii YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Frelii's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Frelii (Frelii) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Frelii Inc (GREY:FRLI) » Definitions » YoY EBITDA Growth
Comparable Companies
ESSI CRVW VYND VASO UCBB TVMDD LBUY USAQ HITC CLNH VEEV TSE:2413 CERN HKSE:01833 TDOC TXG SZSE:300253 ONEM SDGR HQY
Traded in Other Exchanges
N/A
Address
2701 North Thanksgiving Way, Suite 100, Lehi, UT, USA, 84043
Website
http://www.frelii.com
Frelii Inc is a United States-based company engaged in offering web-based subscription service providing personalized nutrition and wellness plans on user's genetic data. It provides an artificial intelligence-based algorithm which generates accurate and valuable insight about individual health risks. The company's algorithm, through a web-based questionnaire, and upload of the user's raw genetic data identifies areas of potential health risk and generates a preventative action plan. The plan includes a personalized nutrition and fitness plan, and nutritional supplement recommendations. In addition, the company also offers nutritional and vitamin supplements. Its product portfolio includes KDIR, BLDB tonic, Keotone-Cocoa, CTV, and others.